Christopher Hunter

IAM Research

The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

Recommended - Individuals: transactions

A prominent name on Canada’s legal landscape, Blake, Cassels & Graydon stands out for the breadth and diversity of its technical expertise and the quality of its practice. The outfit has a deeply talented bench, with experts in the life sciences, technology, oil and gas, and cannabis industries, which ensures that the crew brings home big wins across the patent lifecycle. For example, litigation co-heads Melanie Baird and Andrew Skodyn have been representing Janssen in a long-running and precedent-setting patent impeachment and infringement dispute involving the drugs Remicade, a biological treatment for arthritis, and Inflectra, Canada’s first biosimilar infliximab treatment. Christopher Hunter pulls out all the stops when it comes to ironing out technology licences. He is known for his deft prioritisation of business needs, and recently assisted HgCapital in its strategic investment in CaseWare International, a software company that specialises in accounting solutions.

Unlock unlimited access to all IAM content